Lorazepam - Axium Pharmaceuticals

Drug Profile

Lorazepam - Axium Pharmaceuticals

Alternative Names: Subveta; TRUVETA

Latest Information Update: 04 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Axium Pharmaceuticals
  • Class Antiemetics; Anxiolytics; Benzodiazepinones; Hypnosedatives; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Epilepsy; Lennox-Gastaut syndrome; Seizures

Most Recent Events

  • 04 Aug 2017 Chemical structure information added
  • 17 Jul 2017 Axium applies for Orphan Drug status in Lennox-Gastaut syndrome in USA
  • 29 Jun 2017 Preclinical trials in Epilepsy in USA (Intranasal) before June 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top